These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 10374174

  • 1. [The effectiveness of recombinant growth hormone in height deficiency due to intrauterine growth retardation].
    Vicens-Calvet E, Seijo G, Potau N, de los Llanos Moreno M, Carrascosa A.
    Med Clin (Barc); 1999 May 08; 112(16):601-5. PubMed ID: 10374174
    [Abstract] [Full Text] [Related]

  • 2. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ, Boonstra VH, Mulder PG, Odink RJ, Stokvis-Brantsma WH, Rongen-Westerlaken C, Mulder JC, Delemarre-Van de Waal H, Reeser HM, Jansen M, Waelkens JJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2003 Dec 08; 59(6):779-87. PubMed ID: 14974922
    [Abstract] [Full Text] [Related]

  • 3. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
    Lanes R, Jakubowicz S.
    J Pediatr; 2002 Nov 08; 141(5):606-10. PubMed ID: 12410186
    [Abstract] [Full Text] [Related]

  • 4. The response to treatment with pituitary growth hormone: the New Zealand experience.
    Livesey JH, Cuneo RC, Donald RA, Harris RG, Ibberston HK, Costello JM, Holdaway IM, Gluckman PD, Fraser TR, Chapman GE.
    N Z Med J; 1989 Aug 09; 102(873):399-402. PubMed ID: 2761875
    [Abstract] [Full Text] [Related]

  • 5. Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: Comparison of intrauterine growth retardation and idiopathic short stature.
    Gascoin-Lachambre G, Trivin C, Brauner R, Souberbielle JC.
    Growth Horm IGF Res; 2007 Jun 09; 17(3):194-200. PubMed ID: 17321775
    [Abstract] [Full Text] [Related]

  • 6. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L, Karachaliou F, Neou P, Papataxiarchou K, Pistevos G, Bartsocas CS.
    Am J Med Genet; 1997 Oct 03; 72(1):71-6. PubMed ID: 9295079
    [Abstract] [Full Text] [Related]

  • 7. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
    Carvalho LR, de Faria ME, Osorio MG, Estefan V, Jorge AA, Arnhold IJ, Mendonca BB.
    Clin Endocrinol (Oxf); 2003 Dec 03; 59(6):788-92. PubMed ID: 14974923
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M, Cabrol S, Perin L, Ducos B, Bensman A, Le Bouc Y.
    Growth Horm IGF Res; 2000 Dec 03; 10(6):332-41. PubMed ID: 11161964
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug 03; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 10. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V, Di Biase S, Lettiero T, Labella D, Simeone R, Salerno M.
    Clin Endocrinol (Oxf); 2004 Nov 03; 61(5):607-11. PubMed ID: 15521964
    [Abstract] [Full Text] [Related]

  • 11. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
    Codner E, Cassorla F, Tiulpakov AN, Mericq MV, Avila A, Pescovitz OH, Svensson J, Cerchio K, Krupa D, Gertz BJ, Murphy G.
    Clin Pharmacol Ther; 2001 Jul 03; 70(1):91-8. PubMed ID: 11452249
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Srivuthana S.
    J Med Assoc Thai; 2007 Oct 03; 90(10):2047-52. PubMed ID: 18041422
    [Abstract] [Full Text] [Related]

  • 13. Growth factors and intrauterine growth retardation. II. Serum growth hormone, insulin-like growth factor (IGF) I, and IGF-binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects: prospective study from birth to two years of age. Study Group of IUGR.
    Leger J, Noel M, Limal JM, Czernichow P.
    Pediatr Res; 1996 Jul 03; 40(1):101-7. PubMed ID: 8798254
    [Abstract] [Full Text] [Related]

  • 14. Head circumference and body proportions before and during growth hormone treatment in short children who were born small for gestational age.
    Arends NJ, Boonstra VH, Hokken-Koelega AC.
    Pediatrics; 2004 Sep 03; 114(3):683-90. PubMed ID: 15342839
    [Abstract] [Full Text] [Related]

  • 15. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M, Müller J, Svendsen OL, Kastrup KW, Juul A, Feldt-Rasmussen U.
    Clin Endocrinol (Oxf); 2005 Jan 03; 62(1):18-23. PubMed ID: 15638865
    [Abstract] [Full Text] [Related]

  • 16. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Sep 03; 69(3):443-51. PubMed ID: 18363884
    [Abstract] [Full Text] [Related]

  • 17. Comparison between weight-based and IGF-I-based growth hormone (GH) dosing in the treatment of children with GH deficiency and influence of exon 3 deleted GH receptor variant.
    Marchisotti FG, Jorge AA, Montenegro LR, Berger K, de Carvalho LR, Mendonca BB, Arnhold IJ.
    Growth Horm IGF Res; 2009 Apr 03; 19(2):179-86. PubMed ID: 19036620
    [Abstract] [Full Text] [Related]

  • 18. Serum leptin and IGF-I during growth hormone treatment in chronic renal failure.
    Patel L, Webb NJ, Bradbury MG, Zaman N, Smith P, Lewis MA, Postlethwaite RJ, Price DA, Clayton PE.
    Pediatr Nephrol; 2002 Aug 03; 17(8):643-7. PubMed ID: 12185474
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.
    Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R, Attanasio AF.
    J Pediatr; 2005 Jan 03; 146(1):45-53. PubMed ID: 15644821
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS.
    Clin Nephrol; 1999 Aug 03; 52(2):103-9. PubMed ID: 10480221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.